Navigation Links
BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008
Date:9/4/2008

ss before income taxes (19,928) (4,849) (29,235) (13,377)

Provision for income taxes 80 72 290 195

Net loss $(20,008) $(4,921) $(29,525) $(13,572)

Net loss per common share, basic

and diluted $(0.43) $(1.20) $(0.94) $(3.54)

Weighted-average number of

common shares used in per

share calculation, basic

and diluted 46,257 4,104 31,276 3,839

BIOFORM MEDICAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

(in thousands)

Years Ended June 30,

2008 2007

Assets

Current assets:

Cash and cash equivalents $59,204 $17,610

Accounts receivable, net of allowance for

doubtful accounts of $836 at June 30, 2008

and $428 at June 30, 2007, 10,989 7,725

Inventories 8,167 4,864

Prepaid royalties 929 -

Prepaid other 1,603 1,194

Other current assets 805 262

Total current assets 81,697 31,655

Property and equipment, net 9,037 5,741

Prepaid royalties 3,288 -

Other assets 548 103

Total assets $94,570 $37,499

Liabilities and stockholders' equity

Current liabilities:

Accounts payable
'/>"/>

SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PharmaBoardroom,s new report, , Healthcare and Life ... free download , digs deep into this vibrant market, speaking ... today. One area where Algeria ... homegrown pharmaceutical manufacturing base, even if the government,s ambitious target ... A cursory comparison with neighboring Morocco ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
(Date:12/22/2014)... Malvern, PA & Brussels (PRWEB) December 22, 2014 ... Education (CfPIE), the global leader of technical training ... Society for Clinical Data Management (SCDM) to ... training and certification programs —providing access to the ... The partnership extends SCDM members with 10% off when ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of autologous ... out of the University of Calgary in conjunction with ... Carolina, which further validates the company,s ongoing clinical research ... effects of pattern baldness. The paper entitled ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
... Sonic Foundry reported revenue up 86 percent and a narrowed ... presentation hardware and software for business, government and education. , ... $4.4 million. The company still had a $4.2 million net ... , ,All of this is the effect of the firm's ...
... financing of health care in the United States are enough ... About one in seven Americans (15.7 percent) lack health insurance. ... to the latest federal figures, health spending accounts for 15.3 ... trillion in 2003 works out to $5,670 for each American. ...
... New Year and time for pundits everywhere to predict every possibility ... the more I looked at it, the more it became obvious ... share this with a minor tremor of trepidation. I worked in ... with increasing certainty as the "Year of the LAN." ...
Cached Biology Technology:Health care economics make definition of 'cost' problems difficult 2Health care economics make definition of 'cost' problems difficult 3The year of working together (really!) 2The year of working together (really!) 3
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
(Date:12/5/2014)... 4, 2014 Increased emphasis on product ... new testing and inspection technologies. The convergence of ... a range of innovative test solutions. This trend ... Y, which is generally more inclined towards communication, ... development strategies of test equipment vendors will cater ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... programmable "molecular robot" a sub-microscopic molecular machine made ... by 6nm. The robot, a short strand of DNA, ... determining its destination, for example, to turn left or ... which represents a step toward futuristic nanomachines and nanofactories, ...
... comforting tuck-them-in-words "Sleep tight, don,t let the bedbugs ... people as the world experiences a resurgence of an ... and the risk of exposure to potentially toxic materials. ... current edition of Chemical & Engineering News (C&EN), ACS, ...
... The European Society for Clinical and Economic ... International Osteoporosis Foundation (IOF) have announced that Professor ... is to be awarded the first Herbert A. ... researcher whose groundbreaking work contributed to the development ...
Cached Biology News:Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty 2
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
MOUSE ANTI SIMIAN VIRUS 5:FITC Immunogen: Simian virus 5...
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
... Purification Kit is designed to purify double-stranded DNA ... synthesis and PCR. The process is simple and ... 3 g can be efficiently purified and concentrated. ... DNA is bound to the Microfilter Cartridge in ...
Biology Products: